It was ultimately dropped from human trials after showing the dangerous cardiac side effect of QT prolongation, but is still widely used in animal research into H3 antagonists / inverse agonists.
It was eventually ruled out for human testing due to its severe cardiac side effect of QT prolongation, however, it is still utilized in animal studies examining H3 receptor blockers/antagonists.